Laboratory medicine in the era of precision medicine – dream or reality?
References
- 1. https://ghr.nlm.nih.gov/primer/precisionmedicine/precisionvspersonalized
- 2. https://obamawhitehouse.archives.gov/blog/2015/01/30/precision-medicine-initiative-data-driven-treatments-unique-your-own-body
- 3. Sandberg S, Fraser CG, Horvath AR, Jansen R, Jones G, Oosterhuis W, et al. Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med 2015;53(6):833-5. DOI: 10.1515/cclm-2015-006710.1515/cclm-2015-0067
- 4. Elizabeta Topic, Nora Nikolac, Mauro Panteghini, Elvar Theodorsson, Gian Luca Salvagno, Marijana Miler, et al How to assess the quality of your analytical method?, Clin Chem Lab Med 2015; 53(11): 1707-18. DOI: 10.1515/cclm-2015-086910.1515/cclm-2015-0869
- 5. Federica Braga, Mauro Panteghini, Verification of in vitro medical diagnostics (IVD) metrological traceability: Responsibilities and strategies. Clinica Chimica Acta. May 2014;432:55-61. DOI: 10.1016/j.cca.2013.11.02210.1016/j.cca.2013.11.022
- 6. Siest G, Henny J, Grasbeck R, Wilding P, Petitclerc C, Queralto JM, et al. The theory of reference values: an unfinished symphony. Clin Chem Lab Med 2013;51:4764. DOI: 10.1515/cclm-2012-068210.1515/cclm-2012-0682
- 7. CLSI. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline third edition CLSI document C28-A3. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
- 8. Graham R.D. Jones, Rainer Haeckel, Tze Ping Loh, Ken Sikaris, Thomas Streichert, Alex Katayev, et al, on behalf of the IFCC Committee on Reference Intervals and Decision Limits, Indirect methods for reference interval determination review and recommendations, Clin Chem Lab Med. 2019;57(1):20-29. DOI: 10.1515/cclm-2018-0073
- 9. Hoffmann RG. Statistics in the practice of medicine. JAMA.1963;185:864-873. DOI: 10.1001/jama.1963.0306011006802010.1001/jama.1963.03060110068020
- 10. Katayev A, Balciza C, Seccombe WD, Establishing Referance Intervals for Clinical Laboratory Test Results -is there a better way? Am J Clin Pathol, 2010, 130, 180-186. DOI: 10.1309/AJCPN5BMTSF1CDYP
- 11. Totan M, Gligor FG, Bojita M, Grigore C, Grigore C. Determining hemoglobin reference values in children and teenagers from Sibiu area. Rev Romana Med Lab. 2013;21(1):39-45. DOI: 10.2478/rrlm-2013-001610.2478/rrlm-2013-0016
- 12. Antonescu E, Szakács J, Totan M. Determination of reference intervals for total calcium and magnesium specific for children and adolescents in Sibiu area. Rev Romana Med Lab. 2016;24(3):347-50. DOI: 10.1515/rrlm-2016-003010.1515/rrlm-2016-0030
- 13. Catalin Codreanu, Horatiu Popoviciu, Elena Rezus, Corina Delia Mogosan, Ioannis Gardikiotis, Claudiu Costinel Popescu, Reference interval and upper limit of normal for serum uric acid an evidence-based approach on Romanian population using an a posteriori method, Rev Romana Med Lab. 2019;27(2):147-158. DOI: 10.2478/rrlm-2019-001910.2478/rrlm-2019-0019
- 14. Agnihotri S, Mittal RD, Kapoor R, Mandhani A. Raising cut-off value of prostate specific antigen (PSA) for biopsy in symptomatic men in India to reduce unnecessary biopsy. Indian J Med Res. 2014;139:851-6.
- 15. Xavier Filella,Esther Fernández-Galan,Rosa Fernández Bonifacio, Laura Foj Emerging biomarkers in the diagnosis of prostate cancer. Pharmgenomics Pers Med. 2018 May;1611:83-94. DOI: 10.2147/PGPM.S13602610.2147/PGPM.S136026
- 16. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. ESC Scientific Document Group, Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019 Jan 14;40(3):237-269. DOI: 10.1093/eurheartj/ehy46210.1093/eurheartj/ehy462
- 17. Hadadi L, Sus I, Lakatos EK, Serban RC, Scridon A, Demjen Z, et al. Platelet indices and platelet-to-lymphocyte ratio predict coronary chronic total occlusion in patients with acute ST-elevation myocardial infarction. Rev Romana Med Lab. 2015;23(4):407-14. DOI: 10.1515/rrlm-2015-004110.1515/rrlm-2015-0041
- 18. Martha O, Porav-Hodade D, Bălan D, Tătaru OS, Sin A, Chibelean CB, et al. Easily Available Blood Test Neutrophil-To-Lymphocyte Ratio Predicts Progression in High-Risk Non-Muscle Invasive Bladder Cancer. Rev Romana Med Lab. 2017;25(2):181-9. DOI: 10.1515/rrlm-2017-001610.1515/rrlm-2017-0016
- 19. Balaban DV, Popp A, Beata A, Vasilescu F, Jinga M. Diagnostic accuracy of red blood cell distribution width-to-lymphocyte ratio for celiac disease. Rev Romana Med Lab. 2018;26(1):45-50. DOI: 10.2478/rrlm2018-004010.2478/rrlm2018-0040
- 20. Siegbahn A, Hijazi Z, Lindback J, Oldgren J, Pol T, Alexander JH, et al Screening for novel prognostic biomarkers associated with major bleeding by proximity extension assay in petients with atrial fibrillation on oral anticoagulation: insights from the ARISTOTLE trial, abstract ESC Congress, Aug 2018.
- 21. Hutanu A, Iancu M, Balasa R, Maier S, Dobreanu M Predicting functional outcome of ischemic stroke patients in Romania based on plasma CRP, sTNFR-1, D-Dimers, NGAL and NSE measured using a biochip array, Acta Pharmacologica Sinica 2018: 39(7): 122836. DOI: 10.1038/aps.2018.26
- 22. Daraban AM, Trifa AP, Popp RA, Botezatu D, Șerban M, Uscatescu V, et al. Thrombophilia genetic testing in Romanian young women with acute thrombotic events: role of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and A1298C polymorphisms. Rev Romana Med Lab. 2016;24(3):291-305. DOI: 10.1515/rrlm2016-003210.1515/rrlm2016-0032
- 23. Mărginean A, Bănescu C, Moldovan V, Scridon A, Mărginean M, Bălaşa R, et al. The impact of CYP2C19 loss-of-function polymorphisms, clinical, and demographic variables on platelet response to clopidogrel evaluated using impedance aggregometry. Clin Appl Thromb. 2017; 23:255-65. DOI: 10.1177/107602961662921110.1177/1076029616629211
- 24. Sabin O, Bocșan IC, Trifa A, Major ZZ, Heghes SC, Brusturean Bota E, et al. Correlation between ABCB1 gene polymorphisms, antiepileptic drug concentrations and treatment response. Rev Romana Med Lab. 2018;26(4):479-87. DOI: 10.2478/rrlm-2018-001210.2478/rrlm-2018-0012
- 25. Selleck MJ, Senthil M, Wall NR. Making Meaningful Clinical Use of Biomarkers. Biomark Insights. 2017. 12:1177271917715236. DOI: 10.1177/1177271917715236
- 26. https://www.fda.gov/medicaldevices/productsandmedicalprocedures/invitrodiagnostics/ucm330711.htm, accessed on april 2019
- 27. Goossens N, Nakagawa S, Sun X, Hoshida Y Cancer biomarker discovery and validation, Transl Cancer Res. 2015 Jun; 4(3): 256–269. DOI: 10.3978/j.issn.2218676X.2015.06.0410.3978/j.issn.2218676X.2015.06.04
- 28. Bin L, Zhang M, Lixia L, Aimin Z, Hua Y, Yanhong S, et al. Down-regulation of miRNA-30c predicts poor prognosis in Colorectal Cancer patients. Rev Romana Med Lab. 2016;24(4):369-75. DOI: 10.1515/rrlm-2016-003710.1515/rrlm-2016-0037
- 29. Gao LW, Wang GL. miR-190, CDK1, MCM10 and NDC80 predict the prognosis of the patients with lung cancer. Rev Romana Med Lab. 2019;27(1):15-24. DOI: 10.2478/rrlm-2019-0001
- 30. Bedreag OH, Rogobete AF, Cradigati CA, Sarandan M, Nartita R, Horhat FG, et al. A novel evaluation of microvascular damage in critically ill polytrauma patients by using circulating microRNAs. Rev Romana Med Lab. 2016;24(1):21-30. DOI: 10.1515/rrlm-2016-001510.1515/rrlm-2016-0015
- 31. https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM509838.pdf, accessed on april 2019
Language: English
Page range: 115 - 124
Submitted on: Mar 30, 2019
Accepted on: Apr 11, 2019
Published on: May 2, 2019
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2019 Minodora Dobreanu, Oana Roxana Oprea, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.